Utbildning

The Sanofi webinar ‘Act Now for Impact: Glycemic Control and Beyond’ focuses on recent advancements in treating type 2 diabetes (T2D), emphasizing a personalized approach for better outcomes. Prof. Frank Nobels (Belgium), prof. De Galan (the Netherlands) and Prof Björn Eliasson (Sweden) addressed various aspects of T2D treatment in the present era.

Roth Eli M et al. Atherosclerosis vol. 254 (2016): 254-262

Prof. Dr. Halvorsen, Prof. Dr. Sinnaeve & Prof. Dr. Martens

In this COPD Research Forum, leading healthcare professionals discuss critical topics such as IL-33, lung function trajectories, and mucus plugging in COPD.

Symposierapporter Sanofi

Sanofi har med hjälp av AI-verktyg förkortat texterna till sammanfattningar samt översatt dem till svenska.

A candidate biomarker for smoldering neuroinflammation in MS.

Paper by Tanja Kuhlmann et al.